K974142 · American Lasers, Inc. · GEX · Jan 28, 1998 · General, Plastic Surgery
Device Facts
Record ID
K974142
Device Name
HM-RUBY
Applicant
American Lasers, Inc.
Product Code
GEX · General, Plastic Surgery
Decision Date
Jan 28, 1998
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 878.4810
Device Class
Class 2
Attributes
Therapeutic
Intended Use
ALL TATTOO REMOVAL OR LIGHTENING EXCEPT FOR TREATMENT OF EPIDERMAL PIGMENTED NEVUS OR FOR TREATMENT OF
Device Story
HM-Ruby is a laser device intended for tattoo removal or lightening. Operated by a physician in a clinical setting. Device emits laser energy to target and break down tattoo pigments in the skin. Clinical benefit is the removal or reduction of unwanted tattoos. Output is controlled by the clinician to achieve desired aesthetic results.
Clinical Evidence
No clinical data provided; substantial equivalence based on 510(k) notification review.
Technological Characteristics
Ruby laser system; intended for dermatological applications. Class II device (Product Code GEX).
Indications for Use
Indicated for tattoo removal or lightening in adult patients. Contraindicated for the treatment of epidermal pigmented nevus.
Regulatory Classification
Identification
(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
Related Devices
K973867 — SCHWARTZ ELECTRO-OPTICS, INC. CRYSTALASE 755 LASER SYSTEM · Schwartz Electro-Optics, Inc. · Feb 10, 1998
K961279 — SHARPLAN LASERS, INC. RUBY LASER SYSTEM · Sharplan Lasers, Inc. · Jun 18, 1996
K970475 — MM-RUBY · American Lasers, Inc. · Sep 29, 1997
K964818 — ORION SERIES SURGICAL LASER SYSTEM (Q-SWITCHED ND:YAG CONFIGURATION) · Laserscope · Jun 17, 1997
K011677 — MEDLITE Q-SWITCHED ND:YAG LASER REPLACED BY THE MEDLITE C3 Q-SWTICHED ND:YAG LASER · Continuum Electro-Optics, Inc. · Jun 22, 2001
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized eagle-like symbol with three curved lines representing the bird's body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the symbol. The seal is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 28 1998
David K. Ouon. MD. President American Lasers, Incorporated 300 East Main Street Alhambra, California 91801
K974142 Re:
> Trade Name: HM-Ruby Regulatory Class: II Product Code: GEX Dated: November 1, 1997 Received: November 3, 1997
Dear Dr. Quon:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the --current Good Manufacturing Practice requirements , as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (OS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for
{1}------------------------------------------------
Page 2 - Dr. Quon
devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Cla atta
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
P01
| Page | of | |
|------|----|--|
|------|----|--|
K 97 4142 510(k) Number (if known): KU B l)evice Name:_ Indications For Use:
ALL 7A7700 FOR 02 (D) LIGHTENING RED I-xcEPT
R TONIC 7-0 R JRZATMENT 1 151 FRIDERMAL PIGATENTED
0 L o 7 A NEVUS of FOR RZATMITENT (
(PLEASE DO NOT WRITE BELOW THIS-LINE - CONTINUE ON ANOTHER PAGE IF NEEDDED)
Concurrence of CDRH, Office of Device Evaluation (ONF)
(Division Sign-Off)
Division of General Restorative Devices..
510(k) Number K974142
OR
Prescription Use (Per 21 CFR 801.109)
Over-Tle-Countor Use
(Optional Format 1-2-96)
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.